These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29305285)

  • 1. National Healthcare Safety Network laboratory-identified Clostridium difficile event reporting: A need for diagnostic stewardship.
    Rock C; Pana Z; Leekha S; Trexler P; Andonian J; Gadala A; Carroll KC; Maragakis LL;
    Am J Infect Control; 2018 Apr; 46(4):456-458. PubMed ID: 29305285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 2 Clostridium difficile surveillance methods: National Healthcare Safety Network's laboratory-identified event reporting module versus clinical infection surveillance.
    Gase KA; Haley VB; Xiong K; Van Antwerpen C; Stricof RL
    Infect Control Hosp Epidemiol; 2013 Mar; 34(3):284-90. PubMed ID: 23388363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between National Healthcare Safety Network laboratory-identified event reporting versus traditional surveillance for Clostridium difficile infection.
    Durkin MJ; Baker AW; Dicks KV; Lewis SS; Chen LF; Anderson DJ; Sexton DJ; Moehring RW
    Infect Control Hosp Epidemiol; 2015 Feb; 36(2):125-31. PubMed ID: 25632994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile Infection in Long-term Care Facilities: A Call to Action for Antimicrobial Stewardship.
    Chopra T; Goldstein EJ
    Clin Infect Dis; 2015 May; 60 Suppl 2():S72-6. PubMed ID: 25922404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of Clostridium difficile infection surveillance systems in Europe, 2011.
    Kola A; Wiuff C; Akerlund T; van Benthem BH; Coignard B; Lyytikäinen O; Weitzel-Kage D; Suetens C; Wilcox MH; Kuijper EJ; Gastmeier P;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27469420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overreporting healthcare-associated C. difficile: A comparison of NHSN LabID with clinical surveillance definitions in the era of molecular testing.
    Albert K; Ross B; Calfee DP; Simon MS
    Am J Infect Control; 2018 Sep; 46(9):998-1002. PubMed ID: 29655671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
    Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial stewardship and Clostridium difficile-associated diarrhea.
    Piacenti FJ; Leuthner KD
    J Pharm Pract; 2013 Oct; 26(5):506-13. PubMed ID: 23946208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Use of the Case Mix Index for Risk Adjustment of Healthcare-Associated Infection Data: An Illustration using Clostridium difficile Infection Data from the National Healthcare Safety Network.
    Thompson ND; Edwards JR; Dudeck MA; Fridkin SK; Magill SS
    Infect Control Hosp Epidemiol; 2016 Jan; 37(1):19-25. PubMed ID: 26486597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals.
    Zilberberg MD; Tabak YP; Sievert DM; Derby KG; Johannes RS; Sun X; McDonald LC
    Infect Control Hosp Epidemiol; 2011 Jul; 32(7):649-55. PubMed ID: 21666394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between hospital-level antibiotic consumption and incident health care facility-onset Clostridium difficile infection.
    Crew PE; Rhodes NJ; O'Donnell JN; Miglis C; Gilbert EM; Zembower TR; Qi C; Silkaitis C; Sutton SH; Scheetz MH
    Am J Infect Control; 2018 Mar; 46(3):270-275. PubMed ID: 29169938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.
    Jarvis WR; Schlosser J; Jarvis AA; Chinn RY
    Am J Infect Control; 2009 May; 37(4):263-70. PubMed ID: 19278754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inappropriate Clostridium difficile Testing and Consequent Overtreatment and Inaccurate Publicly Reported Metrics.
    Kelly SG; Yarrington M; Zembower TR; Sutton SH; Silkaitis C; Postelnick M; Mikolajczak A; Bolon MK
    Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1395-1400. PubMed ID: 27666285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile Infections in Veterans Health Administration Long-Term Care Facilities.
    Reeves JS; Evans ME; Simbartl LA; Kralovic SM; Kelly AA; Jain R; Roselle GA
    Infect Control Hosp Epidemiol; 2016 Mar; 37(3):295-300. PubMed ID: 26686361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm.
    Schultz K; Sickbert-Bennett E; Marx A; Weber DJ; DiBiase LM; Campbell-Bright S; Bode LE; Baker M; Belhorn T; Buchanan M; Goldbach S; Harden J; Hoke E; Huenniger B; Juliano JJ; Langston M; Ritchie H; Rutala WA; Smith J; Summerlin-Long S; Teal L; Gilligan P
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29997201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.
    Weiner LM; Fridkin SK; Aponte-Torres Z; Avery L; Coffin N; Dudeck MA; Edwards JR; Jernigan JA; Konnor R; Soe MM; Peterson K; McDonald LC
    MMWR Morb Mortal Wkly Rep; 2016 Mar; 65(9):235-41. PubMed ID: 26963489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions.
    Wilkinson K; Gravel D; Taylor G; McGeer A; Simor A; Suh K; Moore D; Kelly S; Boyd D; Mulvey M; Mounchili A; Miller M;
    Am J Infect Control; 2011 Apr; 39(3):177-82. PubMed ID: 21458680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital.
    Kallen AJ; Thompson A; Ristaino P; Chapman L; Nicholson A; Sim BT; Lessa F; Sharapov U; Fadden E; Boehler R; Gould C; Limbago B; Blythe D; McDonald LC
    Infect Control Hosp Epidemiol; 2009 Mar; 30(3):264-72. PubMed ID: 19215193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Process Approach to Decreasing Hospital Onset Clostridium difficile Infections.
    Abbasi S; Singh F; Griffel M; Murphy PF
    Jt Comm J Qual Patient Saf; 2020 Mar; 46(3):146-152. PubMed ID: 31761522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.
    Truong CY; Gombar S; Wilson R; Sundararajan G; Tekic N; Holubar M; Shepard J; Madison A; Tompkins L; Shah N; Deresinski S; Schroeder LF; Banaei N
    J Clin Microbiol; 2017 May; 55(5):1276-1284. PubMed ID: 28250001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.